| 4LWT: reference: Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy., Zhang Z, Ding Q, Liu JJ, Zhang J, Jiang N, Chu XJ, Bartkovitz D, Luk KC, Janson C, Tovar C, Filipovic ZM, Higgins B, Glenn K, Packman K, Vassilev LT, Graves B, Bioorg Med Chem. 2014 Jun 11. pii: S0968-0896(14)00431-3. doi:, 10.1016/j.bmc.2014.05.072. PMID: 24997575 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).